12:00 AM
 | 
Apr 15, 2013
 |  BC Week In Review  |  Company News  |  Deals

EOS, Servier deal

The companies partnered to co-develop Servier's cancer product E-3810. The small molecule inhibitor of fibroblast...

Read the full 72 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >